EMPAGLIFLOZINA 25 MG COM REV CT BL AL AL X 90
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1351700960200 -
GGREM
543826080109607 -
Código de barras
7898687739374
O que a fonte publica
- Detentor do registro
- ALTHAIA S.A. INDUSTRIA FARMACEUTICA
- Princípios ativos
- EMPAGLIFLOZINA
- Embalagem
- 25 MG COM REV CT BL AL AL X 90
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Genérico
- Classe terapêutica
- A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "EMPAGLIFLOZINA 25 MG COM REV CT BL AL AL X 90",
"holder": "ALTHAIA S.A. INDUSTRIA FARMACEUTICA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7898687739374"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "543826080109607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "48.344.725/0007-19",
"priceRegime": "Regulado",
"productName": "EMPAGLIFLOZINA",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "25 MG COM REV CT BL AL AL X 90",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "387.33",
"icms-12": "440.15",
"icms-17": "466.66",
"icms-18": "472.35",
"icms-19": "478.19",
"icms-20": "484.16",
"icms-21": "490.29",
"icms-22": "496.58",
"icms-23": "503.03",
"icms-17.5": "469.49",
"icms-19.5": "481.16",
"icms-20.5": "487.21",
"icms-22.5": "499.78",
"icms-12-alc": "392.99",
"icms-17-alc": "416.66",
"icms-18-alc": "421.74",
"icms-19-alc": "426.95",
"icms-20-alc": "432.29",
"icms-21-alc": "437.76",
"icms-22-alc": "443.37",
"icms-23-alc": "449.13",
"withoutTaxes": "345.83",
"icms-17.5-alc": "419.19",
"icms-19.5-alc": "429.60",
"icms-20.5-alc": "435.01",
"icms-22.5-alc": "446.23"
},
"pisCofinsList": "Negativa",
"substanceText": "EMPAGLIFLOZINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "519.59",
"icms-12": "590.45",
"icms-17": "626.01",
"icms-18": "633.64",
"icms-19": "641.47",
"icms-20": "649.48",
"icms-21": "657.71",
"icms-22": "666.14",
"icms-23": "674.80",
"icms-17.5": "629.80",
"icms-19.5": "645.46",
"icms-20.5": "653.57",
"icms-22.5": "670.44",
"icms-12-alc": "543.29",
"icms-17-alc": "576.01",
"icms-18-alc": "583.03",
"icms-19-alc": "590.23",
"icms-20-alc": "597.62",
"icms-21-alc": "605.18",
"icms-22-alc": "612.93",
"icms-23-alc": "620.90",
"withoutTaxes": "478.09",
"icms-17.5-alc": "579.51",
"icms-19.5-alc": "593.90",
"icms-20.5-alc": "601.38",
"icms-22.5-alc": "616.89"
},
"invalidBarcodes": [],
"activeSubstances": [
"EMPAGLIFLOZINA"
],
"therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1351700960200",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10P1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:543826080109607"